Global Clinical Trial Solutions To Support Pharma Biomarker Programmes (US, EU, APAC)

• Custom assay development, validation, delivery and monitoring for global trials
• Platform choice, regulatory approach, LDT vs Kit considerations for global trials
• How Almac has supported global clinical trials: Case studies including oncology and chronic disease examples

Speakers:

Leeona Galligan

Global Vice President of Clinical Testing

Almac Diagnostic Services